Interleukin-3 induces hepatocyte-specific metabolic activity in bone marrow-derived liver stem cells.
AuthorsInderbitzin D, Avital I, Keogh A, Beldi G, Quarta M, Gloor B, Candinas D
JournalJ Gastrointest Surg
PubMed ID15623447
Bone marrow-derived adult liver stem cells (BALSC) are a promising target for the development of future cell-based therapies for a variety of liver disorders. However, the ability of stem cells to fully function, as hepatocytes, is limited and differentiation is time dependent. Therefore, it will be conducive to find a ... More